Collaboration will combine AbbVie's oncology expertise and Xilio's proprietary tumor-activation technology to develop novel immunotherapies, including masked T-cell ...

We recently published a list of 10 Best Annual Dividend Stocks To Buy Now. In this article, we are going to take a look at where Roche Holding AG (OTC:RHHBY) stands against other best annual dividend ...

Eli Lilly and Company's impressive Q4 earnings driven by tirzepatide's success, diverse portfolio, and promising pipeline.

Q4 2024 Earnings Call Transcript February 5, 2025 Operator: Good day, and welcome to The Hanover Insurance Group’s Fourth ...

The upscale French furniture-maker posted preliminary revenues of 414 million euros for the full year, but said its fourth ...

Switzerland's pharmaceutical giant Roche has demonstrated remarkable operational performance in fiscal year 2024, with core operating profit surging 14 percent to 20.8 billion Swiss francs.

Report from the Institute for Scientific Information shows how academic research drives global innovation and benefits society LONDON, Jan. 30, 2025 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT) ...

Issued on behalf of Avant Technologies Inc. Teladoc Health has more than 1 million active enrollees across its chronic condition programs, which leverage connected devices, data-driven personalization ...

Issued on behalf of Avant Technologies Inc. VANCOUVER, BC, Jan. 29, 2025 /PRNewswire/ -- USA News Group News Commentary – As the new administration starts to make its mark in the United States ...

At close: January 29 at 2:26:58 PM EST FRANKFURT (Reuters) -Roche said on Thursday it is targeting a continued increase in adjusted earnings per share (EPS) at a high single-digit percentage this ...

Reveal insider sentiment with alternative data that tracks buy and sell trades made by top managers and company directors.